Contrast agent for blood flow approved by FDA
"The U.S. Food and Drug Administration today approved Vasovist Injection (gadofosveset trisodium), the first contrast imaging agent for use in patients undergoing magnetic resonance angiography, or MRA, a minimally invasive test for examining blood vessels."
FDA Approves First Imaging Agent To Enhance Scans Of Blood Flow - Helps Detect Possible Blood Vessel Problems. Medical News Today
Contrast agent for blood flow approved by FDA Reviewed by Sumer Sethi on Monday, January 05, 2009 Rating: